最近文献中的一项前瞻性随机研究表明,局部化学免疫治疗明显改善患3期胰腺癌病人的状况。 希腊雅典医学中心Dr.Nikolaos J.Lygidakis及其同事认为,外科切除仍然是处理胰腺癌的标准方法,尽管医院早期病死率和发病率提高了许多,但长期的总存活结局仍不能令人满意,特别对进行外科切除的3期胰腺癌患者更是如此。 A recent prospective randomized study in the literature shows that topical immunotherapy has significantly improved the condition of patients with stage 3 pancreatic cancer. According to Dr. Nikolaos J. Lygidakis and colleagues at the Athens Medical Center in Athens, surgical resection is still the standard method of treating pancreatic cancer. Although the hospital’s early mortality and morbidity are much higher, the long-term overall survival is still unsatisfactory, This is especially true for patients with stage 3 pancreatic cancer undergoing surgical resection.